Projects per year
Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 3 Similar Profiles
Prostatic Neoplasms
Medicine & Life Sciences
Prostatectomy
Medicine & Life Sciences
Prostate-Specific Antigen
Medicine & Life Sciences
Cystectomy
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Recurrence
Medicine & Life Sciences
Urologic Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2016 2020
Australian hitech manufacturer takes-on prostate cancer
Parkinson, B., Gillatt, D., Krenus, D. & Hicks, R. J.
1/10/17 → 30/09/20
Project: Research
A research assistant to build capacity in and use of Macquarie's bioreactor equipment: towards production and maintenance of live bioartificial tissues for sustainable scientific use
Sen, I., Avolio, A., Gillatt, D., Zvyagin, A., De Deene, Y., Vickery, K., Fuerbach, A. & Parker, L.
1/01/17 → …
Project: Research
assistant
A phase II randomised controlled trial of high dose Vitamin D in localised prostate cancer cases with intermediate risk of progression (Pros-D).
Gurney, H., Butala, R., Nair-Shalliker, V., Smith, D., Gebski, V., Patel, M., Frydenberg, M., Gardiner, R., Kimlin, M., Fenech, M. & Gillatt, D.
1/03/16 → …
Project: Research
A bioreactor complex for automated production and maintenance of live bioartifical tissues
Sen, I., Avolio, A., Gillatt, D., Zvyagin, A., Goldys, E., De Deene, Y. & Kumaraswamy Annayya Chetty Sreenivasan, V.
1/01/16 → 31/12/16
Project: Research
Research Output 1985 2018
An audit of urological MDT decision making in the South West of England
Hounsome, L., Verne, J., Persad, R., Bahl, A., Gillatt, D., Oxley, J., Macdonagh, R., Graham, J. & Pocock, R., 1 Jan 2018, In : Journal of Clinical Urology.Research output: Contribution to journal › Article › Research › peer-review
England
Urologic Neoplasms
Decision Making
National Institutes of Health (U.S.)
Delivery of Health Care
A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
Donovan, J. L., Young, G. J., Walsh, E. I., Metcalfe, C., Lane, J. A., Martin, R. M., Tazewell, M. K., Davis, M., Peters, T. J., Turner, E. L., Mills, N., Khazragui, H., Khera, T. K., Neal, D. E., Hamdy, F. C. & ProtecT Study Group, 1 Apr 2018, In : Journal of Clinical Epidemiology. 96, p. 35-46 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Pragmatic Clinical Trials
Prostatic Neoplasms
Randomized Controlled Trials
Prostate-Specific Antigen
Therapeutics
A systematic review of PFE pre-prostatectomy
Goonewardene, S. S., Gillatt, D. & Persad, R., 21 Mar 2018, In : Journal of Robotic Surgery. p. 1-4 4 p.Research output: Contribution to journal › Article › Research › peer-review
Pelvic Floor
Prostatectomy
Exercise
Muscles
Robotics
Computer-assisted cystoscopy diagnosis of bladder cancer
Gosnell, M. E., Polikarpov, D. M., Goldys, E. M., Zvyagin, A. V. & Gillatt, D. A., Jan 2018, In : Urologic Oncology: Seminars and Original Investigations. 36, 1, p. 8.e9-8.e15 8 p., 8.Research output: Contribution to journal › Article › Research › peer-review
Computer-Assisted Diagnosis
Cystoscopy
Urinary Bladder Neoplasms
Referral and Consultation
Triage
Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial
Martin, R. M., Donovan, J. L., Turner, E. L., Metcalfe, C., Young, G. J., Walsh, E. I., Lane, J. A., Noble, S., Oliver, S. E., Evans, S., Sterne, J. A. C., Holding, P., Ben-Shlomo, Y., Brindle, P., Williams, N. J., Hill, E. M., Ng, S. Y., Toole, J., Tazewell, M. K., Hughes, L. J. & 7 others, 6 Mar 2018, In : JAMA - Journal of the American Medical Association. 319, 9, p. 883-895 13 p.Research output: Contribution to journal › Article › Research › peer-review
Prostate-Specific Antigen
Prostatic Neoplasms
Randomized Controlled Trials
Mortality
Control Groups